Global Targeted Sequencing and Resequencing Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Targeted Sequencing and Resequencing Market Insights, Forecast to 2034
Market Analysis and InsightsGlobal Targeted Sequencing and Resequencing Market
Global Targeted Sequencing and Resequencing market is expected to reach to US$ 46 million in 2023, with a positive growth of %, compared with US$ 45 million in 2022. Backed with the increasing demand from downstream industries, Targeted Sequencing and Resequencing industry is evaluated to reach US$ 57 million in 2033. The CAGR will be 3.6% during 2023 to 2033.
The market trend for targeted sequencing and resequencing is experiencing significant growth. This can be attributed to several factorsAdvancements in sequencing technologiesThe development of high-throughput sequencing technologies, such as next-generation sequencing (NGS), has revolutionized the field of genomics. These technologies enable cost-effective and rapid sequencing of DNA and RNA samples. Targeted sequencing and resequencing techniques, which focus on specific regions of the genome or specific genetic variants, have become increasingly popular due to their efficiency and affordability.
Report Covers
This report presents an overview of global Targeted Sequencing and Resequencing market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Targeted Sequencing and Resequencing market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Agilent Technologies
Illumina
F. Hoffmann-La Roche
Thermo Fisher Scientific
DNASTAR
PacBio
Bio-Rad Laboratories
Integrated DNA Technologies
Perkin Elmer
RainDance Technologies
PierianDx
BGI
Genomatix GmbH
Macrogen
GATC Biotech Ag
Oxford Nanopore Technologies
QIAGEN
Segment by Type
DNA-based Targeted Sequencing
RNA-based Targeted Sequencing
Clinical Application
Plant and Animal Sciences
Drug Development
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Targeted Sequencing and Resequencing introduction, etc. Targeted Sequencing and Resequencing Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Targeted Sequencing and Resequencing
Chapter 13Methodology and Data Sources adopted by MRAResearch
Global Targeted Sequencing and Resequencing market is expected to reach to US$ 46 million in 2023, with a positive growth of %, compared with US$ 45 million in 2022. Backed with the increasing demand from downstream industries, Targeted Sequencing and Resequencing industry is evaluated to reach US$ 57 million in 2033. The CAGR will be 3.6% during 2023 to 2033.
The market trend for targeted sequencing and resequencing is experiencing significant growth. This can be attributed to several factorsAdvancements in sequencing technologiesThe development of high-throughput sequencing technologies, such as next-generation sequencing (NGS), has revolutionized the field of genomics. These technologies enable cost-effective and rapid sequencing of DNA and RNA samples. Targeted sequencing and resequencing techniques, which focus on specific regions of the genome or specific genetic variants, have become increasingly popular due to their efficiency and affordability.
Report Covers
This report presents an overview of global Targeted Sequencing and Resequencing market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Targeted Sequencing and Resequencing market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Agilent Technologies
Illumina
F. Hoffmann-La Roche
Thermo Fisher Scientific
DNASTAR
PacBio
Bio-Rad Laboratories
Integrated DNA Technologies
Perkin Elmer
RainDance Technologies
PierianDx
BGI
Genomatix GmbH
Macrogen
GATC Biotech Ag
Oxford Nanopore Technologies
QIAGEN
Segment by Type
DNA-based Targeted Sequencing
RNA-based Targeted Sequencing
Segment by Application
Clinical Application
Plant and Animal Sciences
Drug Development
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Targeted Sequencing and Resequencing introduction, etc. Targeted Sequencing and Resequencing Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Targeted Sequencing and Resequencing
Chapter 13Methodology and Data Sources adopted by MRAResearch